HUP9701264A3 - Aminoacid derivatives, process for producing them and pharmaceutical compositions containing them - Google Patents

Aminoacid derivatives, process for producing them and pharmaceutical compositions containing them

Info

Publication number: HUP9701264A3
Authority: HU; Hungary
Prior art keywords: producing; pharmaceutical compositions; compositions containing; aminoacid derivatives; aminoacid
Prior art date: 1996-07-24

Application number

HU9701264A

Other languages

English (en)

Original Assignee

Genentech Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-07-24

Filing date

1997-07-22

Publication date

2001-02-28

1997-07-22 Application filed by Genentech Inc filed Critical Genentech Inc

1997-09-29 Publication of HU9701264D0 publication Critical patent/HU9701264D0/hu

1998-05-28 Publication of HUP9701264A1 publication Critical patent/HUP9701264A1/hu

2001-02-28 Publication of HUP9701264A3 publication Critical patent/HUP9701264A3/hu

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C277/00—Preparation of guanidine or its derivatives, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C277/08—Preparation of guanidine or its derivatives, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups of substituted guanidines
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/44—Nitrogen atoms not forming part of a nitro radical
- C07D233/48—Nitrogen atoms not forming part of a nitro radical with acyclic hydrocarbon or substituted acyclic hydrocarbon radicals, attached to said nitrogen atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/20—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/06—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D239/08—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms directly attached in position 2
- C07D239/12—Nitrogen atoms not forming part of a nitro radical
- C07D239/16—Nitrogen atoms not forming part of a nitro radical acylated on said nitrogen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/56—Ring systems containing bridged rings
- C07C2603/58—Ring systems containing bridged rings containing three rings
- C07C2603/70—Ring systems containing bridged rings containing three rings containing only six-membered rings
- C07C2603/74—Adamantanes

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Physical Education & Sports Medicine (AREA)
Rheumatology (AREA)
Urology & Nephrology (AREA)
Orthopedic Medicine & Surgery (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Vascular Medicine (AREA)
Pain & Pain Management (AREA)
Ophthalmology & Optometry (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

HU9701264A 1996-07-24 1997-07-22 Aminoacid derivatives, process for producing them and pharmaceutical compositions containing them HUP9701264A3 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE19629816A DE19629816A1 (de)	1996-07-24	1996-07-24	Neue Cycloalkyl-Derivate als Inhibitoren der Knochenresorption und Vitronectinrezeptor-Antagonisten

Publications (3)

Publication Number	Publication Date
HU9701264D0 HU9701264D0 (en)	1997-09-29
HUP9701264A1 HUP9701264A1 (hu)	1998-05-28
HUP9701264A3 true HUP9701264A3 (en)	2001-02-28

Family

ID=7800671

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HU9701264A HUP9701264A3 (en)	1996-07-24	1997-07-22	Aminoacid derivatives, process for producing them and pharmaceutical compositions containing them

Country Status (24)

Country	Link
US (3)	US6399620B1 (hu)
EP (1)	EP0820991B1 (hu)
JP (1)	JP4077535B2 (hu)
KR (1)	KR100541172B1 (hu)
CN (1)	CN1064352C (hu)
AR (1)	AR007961A1 (hu)
AT (1)	ATE371650T1 (hu)
AU (1)	AU726376B2 (hu)
BR (1)	BR9704072A (hu)
CA (1)	CA2211270C (hu)
CZ (1)	CZ234397A3 (hu)
DE (2)	DE19629816A1 (hu)
HK (1)	HK1006779A1 (hu)
HR (1)	HRP970404A2 (hu)
HU (1)	HUP9701264A3 (hu)
ID (1)	ID17615A (hu)
IL (1)	IL121359A0 (hu)
NO (1)	NO311083B1 (hu)
NZ (1)	NZ328388A (hu)
PL (1)	PL189189B1 (hu)
RU (1)	RU2180331C2 (hu)
SK (1)	SK100597A3 (hu)
TW (1)	TW490461B (hu)
ZA (1)	ZA976532B (hu)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE19629816A1 (de)	1996-07-24	1998-01-29	Hoechst Ag	Neue Cycloalkyl-Derivate als Inhibitoren der Knochenresorption und Vitronectinrezeptor-Antagonisten
DE19653647A1 (de) *	1996-12-20	1998-06-25	Hoechst Ag	Vitronectin - Rezeptorantagonisten, deren Herstellung sowie deren Verwendung
US6482821B2 (en)	1996-12-20	2002-11-19	Hoechst Aktiengellschaft	Vitronectin receptor antagonists, their preparation and their use
DE19653645A1 (de) *	1996-12-20	1998-06-25	Hoechst Ag	Vitronectin - Rezeptorantagonisten, deren Herstellung sowie deren Verwendung
US6218387B1 (en)	1996-12-20	2001-04-17	Hoechst Aktiengesellschaft	Vitronectin receptor anatagonists, their preparation and their use
US6313119B1 (en)	1998-01-23	2001-11-06	Adventis Pharma Deutschland Gmbh	Sulfonamide derivatives as inhibitors of bone resorption and as inhibitors of cell adhesion
CA2327673C (en)	1998-04-09	2009-08-25	Meiji Seika Kaisha, Ltd.	Aminopiperidine derivatives as integrin .alpha.v.beta.3 antagonists
US6689754B1 (en)	1998-04-10	2004-02-10	G. D. Searle & Co.	Heterocyclic glycyl β-alanine derivatives
TWI247008B (en) *	1998-04-10	2006-01-11	Searle & Co	Heterocyclic glycyl beta-alanine derivatives
AU3561099A (en) *	1998-04-14	1999-11-01	American Home Products Corporation	Acylresorcinol derivatives as selective vitronectin receptor inhibitors
EP0960882A1 (en) *	1998-05-19	1999-12-01	Hoechst Marion Roussel Deutschland GmbH	Thienyl substituted acylguanidines as inhibitors of bone resorption and vitronectin receptor antagonists
DE19842415A1 (de)	1998-09-16	2000-03-23	Merck Patent Gmbh	Pharmazeutische Zubereitung
FR2786184B1 (fr) *	1998-11-24	2002-09-20	Hoechst Marion Roussel Inc	Nouveaux derives du benzofurane, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant
FR2786182B1 (fr) *	1998-11-24	2001-01-12	Hoechst Marion Roussel Inc	Nouveaux derives d'acylguanidines, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant
AU783992B2 (en)	1998-12-23	2006-01-12	G.D. Searle Llc	Method of using a cyclooxygenase-2 inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
EP1028114A1 (en) *	1999-02-13	2000-08-16	Aventis Pharma Deutschland GmbH	Novel guanidine derivatives as inhibitors of cell adhesion
US6455734B1 (en)	2000-08-09	2002-09-24	Magnesium Diagnostics, Inc.	Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states
BR0012683A (pt) *	1999-07-21	2002-04-16	American Home Prod	Antagonistas bicìclicos seletivos para a integrina alfavbeta3
CA2380009A1 (en) *	1999-07-28	2001-02-08	The Trustees Of The University Of Pennsylvania	Methods of inhibiting osteoclastogenesis
WO2001010844A1 (en)	1999-08-05	2001-02-15	Meiji Seika Kaisha, Ltd.	φ-AMINO-α-HYDROXYCARBOXYLIC ACID DERIVATIVES HAVING INTEGRIN αvβ3 ANTAGONISM
EP1108721A1 (en) *	1999-12-15	2001-06-20	Aventis Pharma Deutschland GmbH	Thienylalanine derivatives as inhibitors of cell adhesion
FR2808798A1 (fr) *	2000-05-09	2001-11-16	Hoechst Marion Roussel Inc	Nouveaux derives antagonistes du recepteur de la vitronectine
EP1197488A1 (en)	2000-10-10	2002-04-17	Aventis Pharma Deutschland GmbH	(2S)-2-(Adamantan-1-ylmethoxycarbonylamino)-3-(4-(2-(1,4,5,6-tetrahydropyrimidin-2-ylcarbamoyl)ethyl)benzoylamino)propionic acid isopropyl ester, its preparation and its use
WO2003059251A2 (en)	2001-10-22	2003-07-24	The Scripps Research Institute	Antibody targeting compounds
FR2847254B1 (fr)	2002-11-19	2005-01-28	Aventis Pharma Sa	Nouveaux derives antagonistes du recepteur de la vitronectine, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les refermant
BRPI0509069B8 (pt) *	2004-03-23	2021-05-25	Pfizer Prod Inc	compostos de imidazol e composição farmacêutica que os compreende para o tratamento de distúrbios neurodegenerativos
FR2870541B1 (fr)	2004-05-18	2006-07-14	Proskelia Sas	Derives de pyrimidines antigonistes du recepteur de la vitronectine
UA87854C2 (en)	2004-06-07	2009-08-25	Мерк Энд Ко., Инк.	N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulators
EP1940802A2 (en) *	2005-09-22	2008-07-09	Pfizer Products Inc.	Imidazole compounds for the treatment of neurological disorders
EP1945262A2 (en) *	2005-10-20	2008-07-23	The Scripps Research Institute	Fc labeling for immunostaining and immunotargeting
JP2012517447A (ja)	2009-02-10	2012-08-02	ザスクリプスリサーチインスティチュート	化学的にプログラムされたワクチン接種法
KR20160147007A (ko)	2014-05-30	2016-12-21	화이자 인코포레이티드	선택적인 안드로겐 수용체 조절제로서의 카보니트릴 유도체
WO2018049068A1 (en)	2016-09-07	2018-03-15	Pliant Therapeutics, Inc.	N-acyl amino acid compounds and methods of use
WO2023275715A1 (en)	2021-06-30	2023-01-05	Pfizer Inc.	Metabolites of selective androgen receptor modulators

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH04367367A (ja)	1991-06-11	1992-12-18	Nkk Corp	ロータリノズル
US5217994A (en) *	1991-08-09	1993-06-08	Merck & Co., Inc.	Method of inhibiting osteoclast-mediated bone resorption by administration of aminoalkyl-substituted phenyl derivatives
US5204350A (en) *	1991-08-09	1993-04-20	Merck & Co., Inc.	Method of inhibiting osteoclast-mediated bone resorption by administration of n-heterocyclicalkyl-substituted phenyl derivatives
DE4207254A1 (de) *	1992-03-07	1993-09-09	Cassella Ag	4-oxo-2-thioxoimidazolidin-derivate
DE4213634A1 (de) *	1992-04-24	1993-10-28	Cassella Ag	2,4-Dioxo-imidazolidin-Derivate
WO1994008577A1 (en) *	1992-10-14	1994-04-28	Merck & Co., Inc.	Fibrinogen receptor antagonists
AU675689B2 (en) *	1992-12-01	1997-02-13	Merck & Co., Inc.	Fibrinogen receptor antagonists
DE4427979A1 (de) *	1993-11-15	1996-02-15	Cassella Ag	Substituierte 5-Ring-Heterocyclen, ihre Herstellung und ihre Verwendung
WO1995032710A1 (en) *	1994-05-27	1995-12-07	Merck & Co., Inc.	Compounds for inhibiting osteoclast-mediated bone resorption
ZA955391B (en) *	1994-06-29	1996-02-09	Smithkline Beecham Corp	Vitronectin receptor antagonists
HUT76344A (en) *	1994-06-29	1997-08-28	Smithkline Beecham Corp	Vitronectin receptor antagonists
DE19548709A1 (de)	1995-12-23	1997-07-03	Merck Patent Gmbh	Tyrosinderivate
DE19629817A1 (de) *	1996-07-24	1998-01-29	Hoechst Ag	Neue Imino-Derivate als Inhibitoren der Knochenresorption und Vitronectinrezeptor-Antagonisten
DE19629816A1 (de) *	1996-07-24	1998-01-29	Hoechst Ag	Neue Cycloalkyl-Derivate als Inhibitoren der Knochenresorption und Vitronectinrezeptor-Antagonisten
CA2277273C (en)	1997-01-17	2008-03-25	Merck & Co., Inc.	Integrin antagonists
US6017925A (en)	1997-01-17	2000-01-25	Merck & Co., Inc.	Integrin antagonists
US6313119B1 (en) *	1998-01-23	2001-11-06	Adventis Pharma Deutschland Gmbh	Sulfonamide derivatives as inhibitors of bone resorption and as inhibitors of cell adhesion
FR2786182B1 (fr) *	1998-11-24	2001-01-12	Hoechst Marion Roussel Inc	Nouveaux derives d'acylguanidines, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant
EP1028114A1 (en) *	1999-02-13	2000-08-16	Aventis Pharma Deutschland GmbH	Novel guanidine derivatives as inhibitors of cell adhesion

1996
- 1996-07-24 DE DE19629816A patent/DE19629816A1/de not_active Withdrawn
1997
- 1997-07-17 EP EP97112198A patent/EP0820991B1/de not_active Expired - Lifetime
- 1997-07-17 AT AT97112198T patent/ATE371650T1/de not_active IP Right Cessation
- 1997-07-17 DE DE59712879T patent/DE59712879D1/de not_active Expired - Lifetime
- 1997-07-22 PL PL97321254A patent/PL189189B1/pl not_active IP Right Cessation
- 1997-07-22 SK SK1005-97A patent/SK100597A3/sk unknown
- 1997-07-22 RU RU97112634/04A patent/RU2180331C2/ru not_active IP Right Cessation
- 1997-07-22 CZ CZ972343A patent/CZ234397A3/cs unknown
- 1997-07-22 CN CN97115461A patent/CN1064352C/zh not_active Expired - Fee Related
- 1997-07-22 AU AU29418/97A patent/AU726376B2/en not_active Ceased
- 1997-07-22 HU HU9701264A patent/HUP9701264A3/hu unknown
- 1997-07-22 NZ NZ328388A patent/NZ328388A/en unknown
- 1997-07-22 AR ARP970103298A patent/AR007961A1/es active IP Right Grant
- 1997-07-22 HR HR19629816.4A patent/HRP970404A2/xx not_active Application Discontinuation
- 1997-07-22 IL IL12135997A patent/IL121359A0/xx not_active IP Right Cessation
- 1997-07-23 CA CA002211270A patent/CA2211270C/en not_active Expired - Lifetime
- 1997-07-23 ZA ZA9706532A patent/ZA976532B/xx unknown
- 1997-07-23 JP JP19715497A patent/JP4077535B2/ja not_active Expired - Lifetime
- 1997-07-23 NO NO19973399A patent/NO311083B1/no unknown
- 1997-07-23 KR KR1019970034365A patent/KR100541172B1/ko not_active Expired - Fee Related
- 1997-07-24 ID IDP972573A patent/ID17615A/id unknown
- 1997-07-24 BR BR9704072A patent/BR9704072A/pt not_active Application Discontinuation
- 1997-08-06 TW TW086110367A patent/TW490461B/zh not_active IP Right Cessation
1998
- 1998-06-18 HK HK98105626A patent/HK1006779A1/xx not_active IP Right Cessation
2000
- 2000-06-29 US US09/606,080 patent/US6399620B1/en not_active Expired - Lifetime
2002
- 2002-05-10 US US10/141,986 patent/US7348333B2/en not_active Expired - Fee Related
2007
- 2007-08-21 US US11/892,235 patent/US20080021055A1/en not_active Abandoned

Also Published As

Publication number	Publication date
CN1179418A (zh)	1998-04-22
SK100597A3 (en)	1998-02-04
ATE371650T1 (de)	2007-09-15
ZA976532B (en)	1998-04-16
IL121359A0 (en)	1998-01-04
TW490461B (en)	2002-06-11
DE19629816A1 (de)	1998-01-29
DE59712879D1 (de)	2007-10-11
AU726376B2 (en)	2000-11-02
EP0820991A2 (de)	1998-01-28
HUP9701264A1 (hu)	1998-05-28
KR100541172B1 (ko)	2006-10-24
NO973399L (no)	1998-01-26
US6399620B1 (en)	2002-06-04
RU2180331C2 (ru)	2002-03-10
CN1064352C (zh)	2001-04-11
CA2211270A1 (en)	1998-01-24
JPH1143476A (ja)	1999-02-16
NO973399D0 (no)	1997-07-23
NO311083B1 (no)	2001-10-08
PL321254A1 (en)	1998-02-02
EP0820991A3 (de)	2000-05-17
ID17615A (id)	1998-01-15
PL189189B1 (pl)	2005-07-29
NZ328388A (en)	1998-07-28
CA2211270C (en)	2009-02-10
AR007961A1 (es)	1999-11-24
HK1006779A1 (en)	1999-03-19
BR9704072A (pt)	1999-01-05
CZ234397A3 (cs)	1998-03-18
HU9701264D0 (en)	1997-09-29
US20030050314A1 (en)	2003-03-13
US7348333B2 (en)	2008-03-25
US20080021055A1 (en)	2008-01-24
JP4077535B2 (ja)	2008-04-16
AU2941897A (en)	1998-02-05
EP0820991B1 (de)	2007-08-29
KR980009241A (ko)	1998-04-30
HRP970404A2 (en)	1998-04-30

Publication	Publication Date	Title
HUP9701264A3 (en)	2001-02-28	Aminoacid derivatives, process for producing them and pharmaceutical compositions containing them
HUP0000323A3 (en)	2002-02-28	N-substituted 2-cyanopyrrolidine derivatives, process for producing them and pharmaceutical compositions containing them
HUP9902850A3 (en)	2000-07-28	Quinazoline derivatives, process for producing them and pharmaceutical compositions containing them
HUP9700344A2 (en)	1997-10-28	Substituted quinazoline derivatives, process for producing them and pharmaceutical compositions containing them
HU9402232D0 (en)	1994-09-28	1-benzene-sulfonyl-1,3-dihydro-indol-2-one derivatives, process for producing them and pharmaceutical compositions containing them
HUP0100723A3 (en)	2002-12-28	Indole derivatives, process for producing them and pharmaceutical compositions containing them
HUP9904521A3 (en)	2001-07-30	Piperazine derivatives, process for producing them and pharmaceutical compositions containing them
HUP9700358A3 (en)	1999-08-30	New oxazolidinon derivatives, process for their preparation and pharmaceutical compositions containing them
HUP9602511A3 (en)	1998-04-28	Aryl-diazinone derivatives, pharmaceutical compositions containing them, and process for producing all these
HUP9802565A3 (en)	2000-01-28	N-benzyl-dioxothiazolidinylmethyl-benzamide derivatives, pharmaceutical compositions containing them and process for producing the same
HUP9802422A3 (en)	2002-02-28	Substituted isoquinoline-3-carboxamide derivatives, process for producing them and pharmaceutical compositions containing them
HUP0003141A3 (en)	2001-04-28	4-phenylpiperidine derivatives, process for producing them and pharmaceutical compositions containing them
HUP9701265A3 (en)	2000-05-29	Imidazoline derivatives, process for producing them and pharmaceutical compositions containing them
HUP9900120A3 (en)	2001-02-28	Benzosulfone derivatives, process for producing them and pharmaceutical compositions containing them
HUP9901739A3 (en)	2000-06-28	Aminoisoquinolines and aminothienopyridine derivatives, process for producing thereof and pharmaceutical compositions containing them
HUP9802653A3 (en)	2000-09-28	Substituted imidazolidine derivatives, process for producing them, and pharmaceutical compositions containing them
HUP9900056A2 (hu)	1999-05-28	Szubsztituált 4-fenil-amino-tiazol-származékok, eljárás előállításukra és ilyen vegyületeket tartalmazó gyógyászati készítmények
HUP0003608A3 (en)	2001-06-28	Tetrahydroisoquinoline derivatives, process for producing them and pharmaceutical compositions containing them
HUP0003267A3 (en)	2002-02-28	Heteroaryl derivatives, pharmaceutical compositions containing them and process for producing them
HUP9602681A1 (en)	1997-09-29	Hydroxy-pyridinone derivatives, process for producing them and pharmaceutical compositions containing them
HUT76065A (en)	1997-06-30	Indole derivatives, pharmaceutical compositions containing them, process for producing them and their use
HUP0002300A3 (en)	2002-01-28	Quinoline-4-carboxamide derivatives, process for producing them, pharmaceutical compositions containing them and their use
HUP9901473A3 (en)	2001-07-30	2,3-benzodiazepine derivatives, process for producing them and pharmaceutical compositions containing them
HUP0002952A3 (en)	2001-11-28	Benzimidazole derivatives, process for producing them, their use and pharmaceutical compositions containing them
HUP9701561A3 (en)	1998-07-28	N-acylated piperidine derivatives, process for producing them, and pharmaceutical compositions containing them

Legal Events

Date	Code	Title	Description
2007-05-02	FD9A	Lapse of provisional protection due to non-payment of fees